Results 1 to 10 of about 19,870 (257)

Dilated cardiomyopathy in childhood [PDF]

open access: yes, 2000
Dilated Cardiomyopathy is an uncommon disease in children but morbidity and mortality in affected patients are high. This review discuses clinical presentation, diagnosis, medical management and prognosis of the condition, with an emphasis on recent ...
Franklin, O.M.
core  

A young man with acute dilated cardiomyopathy associated with methylphenidate [PDF]

open access: yes, 2008
Tor-Bjarne Nymark1, A Hovland2, H Bjørnstad2, E W Nielsen1,31Section for Emergency Medicine; 2Department of Cardiology, Nordland Hospital, Bodø, Norway; 3University of Tromsø, Tromsø, NorwayAbstract: An 18-year-old obese man ...
H Bjørnstad   +7 more
core   +1 more source

Severe dilated cardiomyopathy as an unusual finding in a young infant with mucolipidosis type 2 [PDF]

open access: yes, 2006
A neonate presented with mucopolysaccharidosis-like phenotypic expression and typical signs of dysostosis multiplex but without urinary excretion of glycosaminoglycans.
Mueller, Peter   +2 more
core  

Prevalence of hepatitis C and B virus infection in patients with idiopathic dilated cardiomyopathy in Brazil: a pilot study

open access: yesBrazilian Journal of Infectious Diseases
The idiopathic dilated cardiomyopathy (IDMC) is a disease of the cardiac muscle characterized by systolic dilation and/or dysfunction of one or both ventricles, symptoms of congestive heart failure and risk of early death.
Francisco J.F.B. Reis   +4 more
doaj   +1 more source

Inter- Not Intraindividual Differences in sTWEAK Levels Predict Functional Deterioration and Mortality in Patients with Dilated Cardiomyopathy

open access: yesMediators of Inflammation, 2014
Background. TNF-like weak inducer of apoptosis (TWEAK) has been reported to predict mortality in patients with dilated cardiomyopathy. However, whether it can be used as a biomarker for disease monitoring or rather represents a risk factor for disease ...
Kai-Uwe Jarr   +3 more
doaj   +1 more source

Protein phosphatase 2A anchoring disruptor gene therapy for familial dilated cardiomyopathy

open access: yesMolecular Therapy: Methods & Clinical Development
Familial dilated cardiomyopathy is a prevalent cause of heart failure that results from the mutation of genes encoding proteins of diverse function. Despite modern therapy, dilated cardiomyopathy typically has a poor outcome and is the leading cause of ...
Xueyi Li   +4 more
doaj   +1 more source

Near missed reversible cardiomyopathy: The value of the electrocardiogram

open access: yesInternational Journal of Pediatrics & Adolescent Medicine, 2015
Dilated cardiomyopathy is a devastating disease affecting the myocardium that is characterized by cardiac chamber dilatation with contractile function impairment in the absence of structural heart disease.
Majid Al-Fayyadh   +3 more
doaj   +1 more source

Research Progress and Forensic Identification of Alcoholic Cardiomyopathy [PDF]

open access: yesFayixue Zazhi, 2019
With the rapid development of the social economy in China, the incidence of diseases caused by excessive drinking is gradually increasing as well. Alcoholic cardiomyopathy refers to long-term high intake of ethanol, and has typical dilated cardiomyopathy
ZHANG Tian-yi, GAO Wei-min, CAO Zhi-peng,et al.
doaj   +1 more source

Modern View on the Dilated Cardiomyopathy

open access: yes, 2014
Introduction. Dilated Cardiomyopathy (DCM) is a chronic disease caused by various conditions which lead to the ventricular dilatation, which decreases their contractile ability of the myocardium.
Yuzych I.
core   +1 more source

Normal Coronary Artery Patient Presenting with Left Ventricular Aneurysm

open access: yesCase Reports in Medicine, 2011
Left ventricular aneurysm (LVA) is one of the most important complications of myocardial infarction LVA is strictly defined as a distinct area of abnormal left ventricular diastolic contour with systolic dyskinesia or paradoxical bulging.
Hakan Altay   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy